肝素涂层覆膜支架腔内治疗TASC C和D级股腘动脉病变:远端流出道血管的影响
单中心回顾性研究纳入2014年12月至2021年5月接受肝素涂层覆膜支架治疗的TASC C或D级股腘动脉病变患者66例,随访中位时间2.6年。29例(43.9%)发生主要肢体不良事件,6、12、24个月一期通畅率分别为74.2%、60.6%、57.6%。流出道血管<2条与支架失败相关(p<0.001),CEVERO分析预测支架失败的准确率为90.0%。
要点
- TASC C/D级股腘动脉病变腔内治疗仍具技术挑战性。
- 流出道血管<2条与支架失败相关(p<0.001)。
- CEVERO分析预测支架失败的准确率为90.0%。
核心结论
- 作者认为流出道是决定TASC C和D级股腘动脉病变腔内治疗结果的最关键因素。
- 作者认为同期行胫动脉血管成形术可能改善覆膜支架的通畅性。
- CEVERO分析可基于常规血管造影图像实时客观估算远端流出道,可能作为术中决策工具,但其临床适用性应在外部验证队列中评估。
研究设计与样本
- 单中心回顾性研究,收集2014年12月至2021年5月于本科室接受治疗的患者。
- 纳入标准:使用一个或多个肝素涂层覆膜支架行TASC C或D级股腘动脉病变腔内治疗,且临床随访>2年。
- 排除标准:临床随访<2年或缺失。
- 共纳入66例患者,其中TASC C型病变11例,TASC D型病变55例;中位随访时间2.6年。
主要发现
- 29例患者(43.9%)发生主要肢体不良事件。
- 6、12、24个月一期通畅率分别为74.2%、60.6%、57.6%。
- 6、12、24个月一期辅助通畅率分别为78.8%、65.2%、59.1%。
- 流出道血管<2条与支架失败相关(p<0.001)。
- CEVERO分析预测支架失败的准确率为90.0%。
临床怎么用
- 原文未据此给出推荐。
局限性
- CEVERO分析的临床适用性应在外部验证队列中评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In the last 2 decades, several studies in the literature evaluated the possible role of covered stents in the treatment of TransAtlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions but, despite the encouraging results, the employment of these devices was never included in clinical guidelines. The aim of this study is to evaluate the role of the technical aspects in patients with TASC C or D lesions that were treated with the GORE VIABAHN endoprosthesis and to elaborate a computerized method to objectively estimate the post-stent run-off and predict stent-graft failure. MATERIALS AND METHODS: In this monocentric retrospective study, we collected the patients who were treated in our department from December 2014 to May 2021. Inclusion criteria comprised: (1) patients who underwent endovascular treatment of a TASC C or D femoropopliteal lesions using one or more heparin-bonded covered stent(s) and (2) clinical follow-up >2 years. Exclusion criteria were clinical follow-up <2 years or missing. An in-house computerized analysis to estimate the post-stent run-off, CEVERO (Computerized Estimation of VEssel Run-Off), was elaborated. RESULTS: Sixty-six patients were enrolled in the study. Eleven patients had a TASC type C lesion, and 55 patients presented a type D lesion. The median follow-up time was 2.6 years. Twenty-nine patients (43.9%) experienced a major adverse limb event. Primary patency after 6, 12 and 24 months was 74.2%, 60.6%, and 57.6%; primary-assisted patency was 78.8%, 65.2%, and 59.1%. The presence of <2 run-off vessels (p<0.001) was correlated with stent-graft failure. The CEVERO analysis demonstrated an accuracy of 90.0% in predicting stent-graft failure. CONCLUSIONS: The treatment of TASC C and D femoropopliteal lesions remains technically challenging. Our study supported the hypothesis that run-off is the most critical factor in determining the outcome of the procedure and that concomitant angioplasty of the tibial vessels might improve the patency of the covered stent. The CEVERO analysis could permit a real-time, objective estimation of the distal run-off using conventional angiographic images, and it might be employed as a tool in the intraprocedural decision-making process, but its clinical applicability should be evaluated on external validation cohorts.Clinical ImpactThe endovascular treatment of TASC C and D femoropopliteal lesions is technically challenging and run-off seems to be the most critical factor in determining the outcome. Concurrent angioplasty of the tibial vessels can create adequate run-off to avoid stent failure. The CEVERO analysis is a computerized estimation of run-off that might be a useful tool in the decision-making process.
引用
- Barabino E, Nivolli A, Pittaluga G, et al. Endovascular Treatment of TASC C and D Femoropopliteal Arterial Disease With Heparin-Bonded Covered Stents: The Impact of Distal Run-Off Vessels. J Endovasc Ther. 2023. PMID: 38140721. doi:10.1177/15266028231219659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。